Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
Abstract Background Accumulating evidence suggests that thiazolidinediones (TZDs) may exert protective effects in atrial fibrillation (AF). The present meta-analysis investigated the association between TZD use and the incidence of AF in diabetic patients. Methods Electronic databases were searched...
Main Authors: | Zhiwei Zhang, Xiaowei Zhang, Panagiotis Korantzopoulos, Konstantinos P. Letsas, Gary Tse, Mengqi Gong, Lei Meng, Guangping Li, Tong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-017-0531-4 |
Similar Items
-
Thiazolidinediones play a positive role in the vascular endothelium and inhibit plaque progression in diabetic patients with coronary atherosclerosis: A systematic review and meta-analysis
by: Cheng Yuan Xue, et al.
Published: (2022-11-01) -
Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan
by: Chin-Hsiao Tseng
Published: (2023-08-01) -
Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia
by: Giorgio Aquila, et al.
Published: (2022-07-01) -
The Effect of Diabetes Mellitus, Insulin, and Thiazolidinediones on Bone Histomorphometry in Streptozotocin-induced Diabetic Postmenopausal Wistar Rats
by: Derya Köseoğlu, et al.
Published: (2021-03-01) -
Inflammation and atrial fibrillation: A comprehensive review
by: Panagiotis Korantzopoulos, et al.
Published: (2018-08-01)